BRIEF-Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600

Reuters
Jul 08
BRIEF-Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600

July 8 (Reuters) - Eton Pharmaceuticals Inc ETON.O:

  • ETON PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ET-600 (DESMOPRESSIN ORAL SOLUTION)

  • ETON PHARMACEUTICALS INC - NDA TARGET ACTION DATE SET FOR FEBRUARY 25, 2026

  • ETON PHARMACEUTICALS INC - ET-600 HAS PATENT PROTECTION THROUGH 2044

  • ETON PHARMACEUTICALS INC - ET-600 ANTICIPATED TO LAUNCH IN Q1 2026

Source text: ID:nGNX1gggCm

Further company coverage: ETON.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10